We show that elevated paladin expression correlated with disease-free survival in colon cancer, and that APC, KRAS, PIK3CA and TP53 oncogenes were significantly more frequently altered in colon cancer patients with high paladin expression. This evidence concerns the gene KRAS and malignant colon neoplasm.